The Phase I CROs received high marks in organization and staff factors
Informing the pharmaceutical drug development, manufacturing and commercialization industry.
CARY, NC – May 18, 2017 – Industry Standard Research (ISR) has released a new report, CRO Quality Benchmarking – Phase I Service Providers (9th Edition), containing findings focused on service provider selection and evaluation. Kevin Olson, CEO, explains, “While some outsourced Phase I projects may lend themselves to a straightforward CRO selection, there are many instances where a sponsor’s ‘go-to’ CRO isn’t the right fit for the job and outsourcers must venture into uncharted waters to find a provider. This is where having access to experiential data becomes critical. Understanding the strengths and weaknesses of Phase I CROs as rated by their customers is paramount in choosing the right CRO for a project.”
ISR surveyed 240 decision-makers at sponsor organizations to gather a comprehensive view of the Phase I service provider landscape. Respondents assess the importance of 27 selection drivers (detailed below) to paint a picture of what is most important in their service provider selection process. Then, respondents evaluate service provider performance along the same dimensions. Using the selection driver data and performance ratings in tandem provides an opportunity for readers to gain a deep understanding of the Phase I outsourcing process and its players.
“Similar to how one might read automobile reviews written by other drivers before buying a car, assessing how well a CRO has performed for recent users can help outsourcing decision-makers choose an appropriate Phase I CRO,” states Olson. “The performance of a couple of Phase I CROs stands out. Celerion receives high marks for its performance in the Organization Factors category while SGS Life Sciences is noted for its performance in Staff Characteristics.”
High performers in Budget Factors, Delivery Factors, and Timelines Management categories are available in the full report. In addition to service provider selection drivers and performance ratings, this report offers insights into the use of preferred providers, cost perceptions/experience, and loyalty metrics, among other areas.
For more information on ISR’s CRO Quality Benchmarking – Phase I Service Providers (9th Edition) report, please visit ISR’s report page.
About Industry Standard Research
Industry Standard Research is the premier, full service market research provider to the pharma and pharma services industries. With over a decade of experience, ISR delivers an unmatched level of domain expertise. For more information about ISR’s off-the-shelf intelligence and custom research offerings, please visit the company’s Web site at www.ISRreports.com, email info@ISRreports.com, or follow ISR on Twitter @ISRreports.